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Gelsolin is an actin-binding/severing protein expressed in intracellular and secreted forms. It is a major regulator of the form
and function of the actin cytoskeleton in most all cells. Here we demonstrate that female mice with a targeted deletion of
the gelsolin gene (Gsn2/2) have defects in mammary gland morphogenesis. Two distinct defects were identified in the
gelsolin-null mammary gland. First, the mammary anlage from Gsn2/2 mice failed to elongate at the onset of puberty and
emained rudimentary until approximately 9 weeks of age, early block (Gsn2/2EB). Second, after the mammary epithelium
ad filled the mammary fat pad, a complete lack of terminal branching, or late block, was observed (Gsn2/2LB). The
sn2/2EB was seen in 70% of Gsn2/2 mice and appeared to be dependent on a modifier gene(s) in addition to the loss of
gelsolin. Gsn2/2LB was observed in all Gsn2/2 mice. Terminal end buds (TEBs) were not evident in the mammary anlage
rom Gsn2/2EB mice until approximately 9 weeks of age. Cellular proliferation in the terminal ductal regions of Gsn2/2EB
females was detected by bromodeoxyuridine incorporation, but was less than that found in the TEBs of age-matched
controls. In mice deficient for gelsolin, mammary gland architecture was unaltered at the histological level. Lobuloalveolar
development was delayed in response to pregnancy in mammary glands of Gsn2/2 mice but was otherwise normal.
Lactation and involution in the gelsolin-null animals were similar to those of wild-type mice. Transplantation of epithelium
devoid of gelsolin into a wild-type (GsnWT) mammary fat pad resulted in proper arborization of the ductal tree.
Transplantation of GsnWT epithelium into the Gsn2/2 fat pad recapitulated the lack of terminal branching seen in
sn2/2 females. These results indicate that gelsolin is required in the mammary stroma for proper ductal morphogenesis.
ur results provide the first evidence of an actin regulatory protein affecting mammary ductal growth through
tromal–epithelial communication. © 2000 Academic Press
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Gelsolin, the patriarch of the actin-binding/severing fam-
ily of proteins, which includes capG, adseverin (scinderin),
villin, advillin, supervillin, and flightless, has a major role
in reorganization and function of the actin cytoskeleton in
response to diverse stimuli (Kwiatkowski, 1999). Gelsolin
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Physiology, University of Cincinnati School of Medicine, Cincin-
nati, OH 45267.
2 To whom correspondence should be addressed. Fax: (716) 845-
482. E-mail: Basch@sc3101.med.buffalo.edu.
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All rights of reproduction in any form reserved.as been shown to affect the activity of several signal
ransducing molecules, including phospholipases Cg, Cb,
Cd, and D, as well as phosphatidylinositol 3 (PI3) kinase
(Kwiatkowski, 1999). Association of gelsolin with phospha-
tidylinositol 4,5-bisphosphate (PIP2) inhibited PLCb and to
lesser extent PLCg activity (Sun et al., 1997). Physiologic
ncreases in Ca21 levels enhanced the affinity of gelsolin for
IP2 (Lin et al., 1997). Gelsolin is removed from the plasma
embrane in response to EGFR signaling (Chen et al.,
996). Movement of gelsolin was caused by EGFR activa-
ion of PLCg, which hydrolyzes PIP2 thus releasing gelsolin
and restoring actin severing function (Chen et al,. 1996). In
addition to PIP2 binding, gelsolin binds and stimulates the
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408 Crowley et al.activity of phospholipase D (Steed et al., 1996). Phospho-
lipase D is involved in the sustained increase in diacylglyc-
erol production from the hydrolysis of phosphatidylcholine
(Exton, 1998; Lee and Rhee, 1995). Gelsolin is also an
effector of rac-mediated actin reorganization during lamel-
lipodia formation in response to growth factors (Azuma et
al., 1998).
Mice lacking the gelsolin gene due to its deletion by
targeted homologous recombination have various defects in
cell type-specific migration events (Witke et al., 1995).
Gelsolin-null mice had increased bleeding times, suggest-
ing altered platelet function, delayed inflammatory re-
sponse because of altered migration of neutrophils, and
slow wound healing due to slow locomotion of dermal
fibroblasts from Gsn2/2 mice, suggesting that gelsolin is
necessary for fibroblast motility (Witke et al., 1995). Indeed,
injection of an antibody that inhibits the actin-filament
severing activity of gelsolin decreases chemoattractive
movement of human gingival fibroblast (Arora et al., 1996).
n addition, cultured hippocampal neurons from Gsn2/2
mice displayed a deficiency in filopodial retraction at the
growth cone (Lu et al., 1997).
We have previously shown that gelsolin is absent or
greatly reduced in 70% of human breast cancers and in
80 –100% of rodent mammary carcinomas induced by
diverse agents (Asch et al., 1996; Dong et al., 1999). Other
nvestigators have also found decreased gelsolin in many
ifferent human tumors by serial analysis of gene expres-
ion and immunohistochemical analysis (Tanaka et al.,
995; Zhang et al., 1997). The gelsolin locus on human
hromosome 9q33 is frequently deleted in cancers of
pithelial origin, including bladder cancer. Reintroduc-
ion of gelsolin into two bladder cancer cell lines inhib-
ted colony formation in soft agar as well as tumor
ormation in nude mice (Tanaka et al., 1995). Gelsolin
eficiency in human breast cancer cell lines is not due to
ene deletion, but rather to an epigenetic mechanism
Mielnicki et al., 1999). Dong et al. (1999) have shown
hat the reduced gelsolin protein levels in these same cell
ines was due to transcriptional downregulation of the
elsolin gene. Interestingly, the degree of reduced gelso-
in protein expression is directly correlated with long-
erm disease-free survival (e.g., complete absence of gel-
olin in tumor cells of a breast cancer correlates with
ecreased survival; H. Asch, unpublished results). These
esults suggest that the loss of gelsolin expression, by
hatever mechanism, may contribute to neoplastic con-
ersion of a particular tissue.
Gelsolin-null mice reproduce normally and have
ormal-sized litters with all pups usually surviving to
eaning. Nevertheless, this does not guarantee that the
ammary gland is entirely normal in Gsn2/2 mice. Our
urpose in the present study was to examine the role of
elsolin in normal mammary gland development, differ-
ntiation, and function. Here we describe two separate
efects in postnatal mammary gland morphogenesis in
he gelsolin knockout mouse. Ductal outgrowth nor-
Copyright © 2000 by Academic Press. All rightally occurs during puberty; however, ductal outgrowth
as delayed in the Gsn2/2EB mammary gland until
pproximately week 9. Terminal end buds (TEBs) were
onexistent in mammary glands from 7-week-old Gsn2/
EB mice. The mammary epithelium appeared to be
unresponsive to hormone induction as proliferation, as-
sessed by BrdU incorporation, was reduced compared to
the TEBs of GsnWT mice. After the mammary anlage in
Gsn2/2EB mice had filled the mammary fat pad, around
2–13 weeks, terminal ductal branching was absent com-
ared to wild-type littermates. The lack of terminal
ranching in virgin mice did not inhibit lobuloalveolar
evelopment during pregnancy, although lobuloalveolar
evelopment was delayed compared to normal mice. The
tructure of the mammary gland from lactating Gsn2/2
mice was indistinguishable from that of wild-type con-
trols. In addition, mammary glands from gelsolin-
deficient mice underwent normal gland restructuring
during involution. Furthermore, reciprocal transplanta-
tion experiments and transplantations utilizing SCID
mice determined that gelsolin was acting within the
stroma to affect mammary ductal morphogenesis.
METHODS AND MATERIALS
Mice
Gelsolin heterozygous (Gsn1/2) mice were generated as de-
scribed (Witke et al., 1995) and backcrossed to place the gelsolin-
null allele on a BALB/c background. However, at the N6 back-
cross generation, Gsn2/2 BALB/c mice displayed embryonic
lethality between E17.5 and birth (Kwiatkowski, 1999). To
overcome this problem, heterozygotes on the mixed BALB/c 3
129/Sv background were bred to generate homozygous null
(Gsn2/2) and wild-type (GsnWT) mice. Genotypes were done on
DNA isolated from tail biopsies via PCR analysis using primers
specific to both the neo insertion cassette (59 ATTGAACAA-
GATGGATTGCAC 39 and 59 CGTCCAGATCATCCTGATC 39)
and the gelsolin locus (59 GTGGAGCACCCCGAATT 39 and 59
CTCAGTTCAGGTATATCCATACAGTT 39). The mice were
maintained as randomly bred stocks of Gsn2/2 and Gsn1/1 in
our mouse colony. Gsn2/2 and GsnWT mice of the same
generation were used in all subsequent studies unless otherwise
stated. Gsn1/1 and Gsn1/2 mice displayed identical pheno-
types with respect to the mammary gland and are referred to as
GsnWT. Due to the paucity of Gsn2/2 females generated by
inbreeding, matings between generations (essentially backcross-
ing) were done to generate the numbers of female Gsn2/2 mice
necessary for experimentation (Fig. 1). This random breeding
scheme eventually resulted in the separation of two mammary
gland phenotypes, an early block (Gsn2/2EB), the original phe-
notype observed, and a late block (Gsn2/2LB) (see Results for
details). To generate mice which most closely resembled the
original gelsolin knockout mice, male Gsn2/2 mice of the
mixed BALB/c 3 129/Sv background were mated with wild-type
129/Sv females. The F1 generation was then mated to generate
the F2 generation, animals of which were kept separate accord-
ing to parental origin and inbred exclusively brother/sister
without any derivations (i.e., interbreeding between parental
lines). This mating scheme recapitulated the original phenotype
s of reproduction in any form reserved.
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late block was the predominant phenotype observed. The F2
generation was used in transplantation experiments (see below)
to assess the late block. The early block phenotype was main-
tained in the mixed background by phenotyping the fourth
inguinal mammary gland of the mice at 6 –7 weeks and then
inbreeding females with the early block to their brothers. For
mastectomies, female mice were anesthetized with ketamine/
xylazine at 0.1 mg/kg body weight, the glands were removed as
described by DeOme and colleagues (1959), and the wounds were
closed using 9-mm wound clips. Two to three weeks postsurgery
the wound clips were removed, and the mice were mated as
described earlier. However, to date a pure Gsn2/2EB mouse line
as not been generated.
Mammary Gland Whole Mounts
The fourth (inguinal) pair of mammary glands was removed
FIG. 1. Diagram of the breeding scheme for the generation and m
reeding pairs were received (only two are depicted here) and used to
he heterozygous matings (F1 mice of Gsn2/2, Gsn1/2, and Gsn1
within the line ([Gsn2/2 L1 3 Gsn2/2 L1] and [Gsn2/2 L2 3 G
aucity of Gsn2/2 mice generated by intercrossing we started br
ated within the line, between lines, or between generations ([Gs
mice were derived in exactly the same manner (not shown). This ra
the disappearance of the early block.postmortem at 4, 7.5, 9, 12, 18, and 24 weeks of age from
Copyright © 2000 by Academic Press. All rightGsn2/2 and GsnWT virgin mice. The isolated glands were
spread on precleaned glass slides and stained using carmine alum
stain (Jones et al., 1996). Tissues were air dried on the slide for
10 min and fixed in 75% ethanol and 25% acetic acid for 4 h. The
glands were placed in distilled water for 5 min then stained in
carmine alum (0.2% carmine and 0.5% aluminum potassium
sulfate in water) overnight. The next day the tissues were
destained through a graded series of alcohol from 70 to 100% for
15 min each. The glands were then placed in acetone for 1 h and
cleared in xylene for 1 h to overnight. The cleared mammary
glands were mounted in Cytoseal and covered with a glass
coverslip. Mammary glands were removed from pregnant ani-
mals at 6.5, 12.5, and 17.5 days postcoitus (dpc). Appearance of a
vaginal plug was considered day 0.5 of pregnancy. Mammary
glands from lactating mice were removed when the pups were
approximately 10 days of age. For mammary glands from invo-
luting mice, the pups were removed at 10 days, and the glands
were removed 24 h, 72 h, and 2 weeks later. Mammary glands
from pregnant, lactating, and involuting mice were processed
nance of Gsn2/2 and GsnWT lines. Three gelsolin heterozygous
erate the colony. Mice of the expected genotypes were derived from
line two). Gsn2/2 mice from the F1 generation were mated either
/2 L2]) or between lines (Gsn2/2 L1 3 Gsn2/2 L2). Due to the
g between generations (i.e., backcrossing). The F2 progeny were
F2 3 Gsn2/2 F2] and [Gsn2/2 F1 3 Gsn2/2 F2]). The GsnWT
mating scheme was continued through several generations untilainte
gen
/1 on
sn2
eedin
n2/2
ndomidentically to those from virgin mice.
s of reproduction in any form reserved.
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410 Crowley et al.Histology
The fourth pair of inguinal mammary glands from each stage of
mammary gland development (from 9- to 18-week-old virgin, 6.5-
to 17.5-dpc pregnant, lactating, and involuting mice) was fixed in
10% neutral buffered formalin for at least 24 h at 25°C. The tissues
were embedded in paraffin and sectioned using standard tech-
niques. Five-micrometer sections were stained with hematoxylin
and eosin.
Transplantation Analysis
Two different sets of transplantations were conducted. In all
cases the transplantations were successful. For the late block
transplantations, mammary epithelium from 3-week-old F2
mice derived from the mixed background BALB/c 3 129/Sv
mating (see above for details) from Gsn2/2 and GsnWT mice
was removed as described (DeOme et al., 1959). Four combina-
tions of epithelium plus stroma were done, (a) Gsn2/2 epithe-
lium into Gsn2/2 fat pad, (b) Gsn2/2 epithelium into GsnWT
fat pad, (c) GsnWT epithelium into Gsn2/2 fat pad, and (d)
GsnWT epithelium into GsnWT fat pad. The mice were eutha-
nized 8 weeks posttransplantation, and the mammary glands
were removed and processed for whole-mount analysis as above.
Since the early block phenotype was maintained on a mixed
genetic background, mammary epithelium from Gsn2/2 and
GsnWT mice was removed at 3 weeks and transplanted into the
cleared mammary fat pads of 3-week-old SCID mice in order to
avoid rejection. Gsn2/2 donor tissue was implanted into one
cleared inguinal mammary fat pad, while the GsnWT tissue was
placed in the contralateral mammary fat pad of the same animal.
The transplants were removed when the epithelium was 10 –11
weeks old (8 weeks posttransplantation) and processed for whole
mounts.
Immunohistochemistry
To assess the proliferative state of mammary epithelial cells,
bromodeoxyuridine (BrdU; 10 mg/ml) was injected ip as de-
cribed by Pierce et al. (1993), and 2 h postinjection the mice
were euthanized, and the fourth inguinal mammary glands were
removed and fixed in 10% neutral-buffered formalin for 24 h at
25°C. Sections of mammary glands were done as described
above. An anti-BrdU antibody (a gift from Dr. George Mayers,
Roswell Park Cancer Institute) was used at a 1:500 dilution. The
PCNA (Ab-1) antibody was purchased from Calbiochem and
used at a 1:1000 dilution. Sections were incubated in xylene to
remove paraffin and then rehydrated through a graded series of
alcohols (100 to 70%) and then into PBS. Endogenous peroxi-
dases were blocked by incubation in 3% H2O2 for 30 min,
ollowed by antigen retrieval in the microwave, 1 min full power
nd then 10 min at 20% power in 0.1 M sodium citrate,
H 6. After incubation with the primary antibody (a-BrdU or
a-PCNA) a biotin-conjugated universal secondary antibody and
he streptavidin/biotin HRP were added as per the directions of
he manufacturer (Vector Stains, CA). Color development oc-
urred with diaminobenzene for 4 min at 25°C. The sections
ere counterstained in hematoxylin, washed extensively in
ater, dehydrated in alcohol and xylene, and mounted in
ytoseal 60. To analyze cells undergoing apoptosis, the
UNEL assay was done according to the manufacturer’s instruc-ions (Intergen, CA). s
Copyright © 2000 by Academic Press. All rightRESULTS
Gelsolin Is Required for Normal Postnatal
Mammary Gland Development
To assess the contribution of the actin-binding/severing
protein gelsolin to mammary gland development, we ana-
lyzed whole mounts of mammary glands from gelsolin-null
mice compared to mammary glands from wild-type, age-
matched controls. Whole-mount analysis of mammary
glands from 4-week-old Gsn2/2 and GsnWT mice showed
no significant differences in overall gland structure (Figs.
2A and 2B). Notable, however, was the complete lack of
TEBs in the Gsn2/2 mammary glands at this stage of
development (Figs. 2A and 2B, arrows). The mammary
anlage in both sets of mice contained between 12 and 15
branches from the main duct. In GsnWT mice at 8–9 weeks
of age, the mammary ductal epithelial tree had grown to
completely fill the mammary fat pad (Fig. 2C). At the same
age, mice homozygous for the gelsolin deletion harbored a
mammary ductal epithelial tree which resembled that of a
3- to 4-week-old wild-type mouse (Fig. 2D). The block in
mammary epithelial outgrowth was overcome with the
appearance of TEBs at approximately 10 weeks of age (for an
example of TEBs at 10 weeks see Fig. 8, Gsn2/2EB donor)
nd the mammary ductal tree grew to completely fill the fat
ad at 12 weeks (Figs. 2E and 2F). At 12 weeks of age large
EBs were still present in the Gsn2/2EB mice, whereas in
he age-matched controls no TEBs were seen (data not
hown). At this point in development, the mammary ductal
ystem of the Gsn2/2 mice contained fewer side branches
nd lacked terminal ductal units (Figs. 2E and 2F). The lack
f terminal branching in the Gsn2/2 mice persisted as long
s the females remained virgins (Fig. 2G and 2H and see
elow). Thus, the mammary glands of virgin Gsn2/2 mice
ontained two separate phenotypes, an early block, wherein
he mammary anlage was rudimentary (i.e., 3 weeks) until
he 9th or 10th week, and a late block, wherein terminal
ranching was absent. In both phenotypes, Gsn2/2EB and
sn2/2LB, the lack of terminal branching was invariant.
Despite the obvious absence of TEBs, histological analysis
of mammary glands from mice 7–9 weeks of age from
Gsn2/2EB and GsnWT mice revealed no differences in
overall ductal architecture as the ducts present were lined
by a single layer of epithelial cells subtended by myoepi-
thelial cells (data not shown). Analysis of mammary gland
sections from 18-week-old mice confirmed the comparative
structure of the Gsn2/2 and GsnWT mice as the ducts of
Gsn2/2 appeared histologically normal in cross section
(data not shown).
Not All Gelsolin2/2 Mice Are Created Equal
After an initial heterozygous breeding of the Gsn1/2
ice to obtain Gsn2/2 and GsnWT mice, the null muta-
ion and wild-type mice were maintained as Gsn2/2 and
sn1/1 intracrosses, respectively (Fig. 1). In mice derivedubsequently from this intracross population, we discov-
s of reproduction in any form reserved.
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411Gelsolin in Mouse Mammary Gland MorphogenesisFIG. 2. Whole-mount analysis of mammary glands from virgin mice. The fourth inguinal mammary gland from wild-type (A, C, E, and
G) and Gsn2/2 (B, D, F, and H) mice, stained with carmine alum (see Methods and Materials for details). In the mammary anlage from a
-week-old female, note the presence of large TEBs in the wild-type gland (A, arrows), while the Gsn2/2 anlage completely lacks TEB
formation (B, arrows). The epithelium from the wild-type mouse has completely filled the fat pad by 9 weeks (C). In contrast, the epithelium
from the Gsn2/2 mouse has not begun to grow and still lacks observable TEBs (D, upper right-hand corner; for an example of TEBs in the
Gsn2/2EB mammary glands at 10 weeks of age see Fig. 8, Gsn2/2EB donor). Mammary glands from 12-week-old wild-type (E) and Gsn2/2
ice (F) display different levels of alveolar development. The GsnWT mammary gland is filled with lateral branching and alveolar bud
evelopment (E) while the Gsn2/2 mammary gland is totally devoid of terminal branching and alveolar bud development (F). Mammary
lands from GsnWT (G) and Gsn2/2 (H) mice at 6 months of age. The lack of terminal branching is maintained in the Gsn2/2 female until
he onset of pregnancy (see Fig. 3). Original magnification in A and B, 33; in C–H, 1.53
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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412 Crowley et al.ered that the Gsn2/2EB phenotype had disappeared. Due to
the mixed genetic background (BALB/c and 129/Sv) of the
original Gsn1/2 mice used to generate Gsn2/2 and
Gsn1/1 stocks, we reasoned that a genetic modifier(s) may
have been responsible for the observed early block pheno-
type. To investigate the basis for this phenomenon we
crossed a Gsn2/2 male (of the mixed BALB/c 3 129/Sv
background) with a 129/Sv female to generate Gsn1/2
mice with a genetic contribution of .50% from the 129/Sv
female. Mice heterozygous for gelsolin were sib-mated
within a parental line. The early block was observed in the
F2 generation; however, in subsequent generations we de-
tected only the late block. These matings have been carried
out for five generations. Therefore, the mammary epithe-
lium from the Gsn2/2LB mice followed a developmental
program similar to that of the GsnWT mice except for the
lack of terminal branching (data not shown). Attempts to
generate a Gsn2/2EB line by intercrossing Gsn2/2EB fe-
males with sibling males have not been successful to date.
The Effect of Pregnancy on Gsn2/2 Mammary
land Development
Since gelsolin-null mice are able to support a full litter to
weaning, we analyzed development of the mammary glands
of Gsn2/2 and GsnWT mice during pregnancy. Gsn2/2
and GsnWT mice were mated, and females became preg-
TABLE 1
Cellular Proliferation Rate in Mammary Glands of Gsn2/2 and
snWT Mice during Pregnancy
No. of cells
counteda
PCNA-positive
cells
Percentage PCNA
positiveb
Gsn2/2
6.5 dpc 4408 1430 32.44 6 0.28
12.5 dpc 4531 1452 32.05 6 0.12
GsnWT
6.5 dpc 5457 3023 55.28 6 0.17
12.5 dpc 5395 2707 50.02 6 0.57
a Total number of cells counted from independent sections from
hree mammary glands representing each genotype.
b Percentage positives are 6 the standard error of the mean for an
5 3 and P , 0.0001.
FIG. 3. Whole-mount analysis of the effects of pregnancy on mam
in Fig. 2. GsnWT (A, C, E, G, I, and K) and Gsn2/2 (B, D, F, H, J, and
day 0.5 of pregnancy. Mammary glands of GsnWT mice displayed in
the Gsn2/2 mammary gland (B and D) had little lobuloalveolar de
the GsnWT gland had markedly increased alveolar content (E and G
gland lagged behind the wild type in the degree of alveolar gro
lobuloalveolar development (I and K), but the Gsn2/2 mammaryriginal magnification for A, B, E, F, I, and J was 33, while that for C,
Copyright © 2000 by Academic Press. All rightnant with similar frequency and timing (i.e., Gsn2/2EB and
sn2/2LB mice became pregnant around 8–9 weeks of age,
omparable to GsnWT mice). Mice were euthanized during
arly (6.5 dpc), mid (12.5 dpc), and late (17.5 dpc) stages of
regnancy, and their mammary glands were removed for
nalysis. Whole mounts of mammary glands from early
regnant (6.5 dpc) Gsn2/2 mice revealed that lobuloalveo-
ar development was indeed taking place, albeit at a reduced
ate compared to the age-matched wild-type control mice
Table 1 and Figs. 3A and 3B). By midpregnancy (12.5 dpc),
he Gsn2/2 mammary gland resembled that of the control
n early pregnancy (6.5 dpc) (Figs. 3E and 3F). During the late
tages of pregnancy the mammary gland was essentially
omparable to the mammary gland of a midpregnant
snWT mouse (Figs. 3I and 3J). Higher magnifications of
ammary whole mounts at these stages confirm the delay
n alveolar development seen between the GsnWT and the
sn2/2 mice (Figs. 3C, 3G, 3K and 3D, 3H, 3L). Mammary
lands removed from Gsn2/2 and GsnWT mice during
actation showed the Gsn2/2 mammary glands to be
ndistinguishable from the GsnWT (data not shown). His-
ological examination of mammary glands in the various
tages of pregnancy revealed normal lobuloalveolar devel-
pment in the Gsn2/2 mammary glands despite the delay
Figs. 4A–4F). Immunohistochemical staining of mammary
pithelium during early pregnancy with an antibody to
CNA showed some cellular proliferation in the terminal
nd structures and developing acini (Figs. 4C and 4D).
taining was very widespread during the mid to late stages
f pregnancy in the Gsn2/2 glands, denoting more exten-
ive cellular proliferation (Figs. 4E and 4F). In the mammary
lands of early (6.5 dpc) pregnant GsnWT mice, approxi-
ately 50% of the epithelial cells were undergoing prolif-
ration as assessed by PCNA immunohistochemistry
Table 1). This rate of cellular proliferation continued
hrough midpregnancy (12.5 dpc) (Table 1). In contrast,
pproximately 30% of the epithelial cells from Gsn2/2
ammary glands at 6.5 dpc stained for PCNA (Table 1). The
ate of proliferation did not change in the mammary glands
rom midpregnant Gsn2/2 mice (Table 1). These results
uggest that the epithelium is capable of responding to the
ormonal milieu produced during pregnancy but the rate of
ellular proliferation in the Gsn2/2 animals is reduced
ompared to that of the GsnWT animals.
y glands lacking gelsolin. The mammary glands were processed as
ice were mated and the appearance of a vaginal plug was considered
sed lobuloalveolar development as early as 6.5 dpc (A and C), while
pment at this stage of pregnancy. During midpregnancy, 12.5 dpc,
did the Gsn2/2 mammary gland (F and H); however, the Gsn2/2
In late pregnancy, 17.5 dpc, the GsnWT gland exhibited dense
d resembled that of a gland from a midpregnant mouse (J and L).mar
L) m
crea
velo
) as
wth.
glanD, G, H, K, and L was 43
s of reproduction in any form reserved.
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414 Crowley et al.Gelsolin Is Dispensable for Mammary Gland
Involution
Cleavage of gelsolin into 39-kDa NH4-terminal and 41-
Da COOH-terminal fragments has been observed during
as-induced activation of apoptosis, releasing an
-terminal fragment with Ca21-independent actin-filament
severing activity (Kothakota et al., 1997). This unrestricted
elsolin fragment has been proposed to be an effector of
aspase 3 and thus a mediator of the apoptotic program, in
everal cell types (e.g., neutrophils) (Kothakota et al., 1997).
ince the mammary gland is restructured following wean-
ng of the pups by apoptosis (Strange et al., 1992), the effect
f loss of gelsolin was analyzed in mammary glands under-
oing involution. Forced weaning of pups from Gsn2/2 and
snWT mice at 10 days postpartum followed by removal of
ammary glands at 24 h, 72 h, and 2 weeks into involution
emonstrated that the Gsn2/2 mammary gland was fully
apable of undergoing epithelial remodeling (apoptosis)
Figs. 5A and 5B and data not shown). TUNEL analysis of
ammary glands confirmed the apoptotic program in mam-
ary epithelial cells from Gsn2/2 mice (Table 2 and Figs.
A and 5B). Therefore, these data suggest that gelsolin is not
equired for apoptosis of the mammary epithelium during
nvolution.
The Early Block: A Failure to Respond to Early
Cues?
To begin to address the cause of the early block
(delayed growth of the epithelial ductal tree) we injected
Gsn2/2EB and GsnWT mice 7 and 9 weeks of age with
rdU, and 2 h postinjection the mice were euthanized.
he fourth pair of inguinal mammary glands was re-
oved and processed for immunohistochemistry. Stain-
ng with an anti-BrdU antibody revealed that the epithe-
ium of GsnWT mice at 6 –7 weeks of age was
roliferating as expected (Fig. 6A). The antibody reaction
ccurred primarily in the TEBs, the site for rapid cellular
roliferation in the growing duct. Mammary epithelium
f Gsn2/2EB mice assayed at 7 weeks had also incorpo-
rated BrdU, indicating growth of the mammary anlage.
However, the number of stained cells in the Gsn2/2EB
gland was reduced compared to that of the wild type
(compare Fig. 6A to 6B and Table 3). In addition, mam-
mary ducts from 7-week-old GsnWT mice showed a
significant level of BrdU incorporation, which increased
by 9 weeks (Fig. 6E). In contrast, the ducts of Gsn2/2EB
mice at 7 weeks were devoid of proliferating cells (Figs.
6C and 6D), but began to show incorporation of BrdU
around 9 weeks (Fig. 6F). BrdU analysis of mammary
epithelium from 7-week-old GsnWT mice revealed that
approximately 1% of the cells were proliferating (Table
3). In contrast, approximately 0.4% of the epithelial cells
from an age-matched Gsn2/2EB mammary gland were
proliferating (Table 3). These results in conjunction with
the total lack of TEBs during this time suggest that the
Copyright © 2000 by Academic Press. All rightammary epithelium of the Gsn2/2EB mice was growing
ery slowly.
The other possibility to explain the absence of terminal
nd bud formation in the Gsn2/2EB mice was an increase in
ellular death. To test this possibility, we utilized the
UNEL assay. Analysis of sections from mammary glands
f 7- and 9-week-old Gsn2/2EB and GsnWT mice did not
reveal a difference between them in cell death through
apoptosis (Figs. 7A and 7B). The presence of a lumen in the
mammary anlage from Gsn2/2EB mice at 7 weeks indicated
poptosis was occurring (Humphreys et al., 1996), as shown
n Fig. 7B. However, we found that increased apoptosis was
ot present throughout the gland (Fig. 7B). Indeed, the
poptotic rate in the Gsn2/2EB mammary epithelium was
pproximately half of that seen in the GsnWT epithelium
Table 4). These results, combined with the eventual out-
rowth and functional differentiation of the mammary
pithelium in the Gsn2/2 mice, strongly suggest that the
pithelial cells failed to respond to early cues for growth and
roliferation and continued to grow slowly.
Stromal Signaling Is Responsible for Both the Early
and the Late Phenotypes
In all Gsn2/2 mice, regardless of the early block, lack of
terminal ductal branching was invariant, suggesting that
this defect resulted from the loss of gelsolin. In addition, the
early block may be due to expression of a modifier gene in
combination with lack of gelsolin, as the early block was
not seen in GsnWT mice with similar genetic profiles. In
order to dissect epithelial from stromal effects on terminal
branching in Gsn2/2 mice, we conducted a series of
reciprocal transplantation experiments. Male gelsolin-null
mice on the mixed background were mated with 129/Sv
females to generate a BALB/c 3 129/Sv F1 generation. The
heterozygous (Gsn1/2) animals were mated to generate the
F2 generation, which was used for the transplantation
analysis. At 3 weeks of age the mammary anlage was
removed from a Gsn2/2 mouse and transplanted into a
single, cleared fourth inguinal fat pad of a 3-week-old
GsnWT mouse (n 5 6). At the same time, GsnWT epithe-
lium was transplanted into the contralateral fourth inguinal
fat pad. Next, GsnWT epithelium (also at 3 weeks) was
transplanted into cleared Gsn2/2 fat pads as described
above. Again, transplantation of mammary anlage from
Gsn2/2 mice into the cleared contralateral fourth inguinal
fat pad served as a control. As seen in Fig. 8, transplantation
of Gsn2/2 epithelium into the cleared fat pad of a GsnWT
host gave rise to normal ductal arborization with extensive
terminal branching. Conversely, introduction of wild-type
epithelium into the Gsn2/2 stromal environment reca-
pitulated the lack of terminal branching seen in the epithe-
lium of Gsn2/2 mice (Fig. 8). Therefore, these data strongly
suggest that gelsolin is acting within the stromal compart-
ment of the mammary gland to effect proper ductal mor-
phogenesis.Transplantations were also done to determine the
s of reproduction in any form reserved.
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415Gelsolin in Mouse Mammary Gland MorphogenesisFIG. 4. Histology and immunostaining of proliferating cell nuclear antigen in mammary glands from GsnWT and Gsn2/2 mice
uring pregnancy. Mammary glands were removed from females at different times during pregnancy and analyzed for PCNA staining
y immunohistochemistry. Mammary glands from 6.5-dpc GsnWT (A) and Gsn2/2 (B) females were analyzed for overall histology by
&E staining. Sections from the same time period were stained with an anti-PCNA antibody to detect cells in S phase of the cell cycle
see Methods and Materials for details about immunohistochemistry). Mammary glands from GsnWT pregnant mice (C) at 6.5 dpc
howed several reactive nuclei as did mammary glands from Gsn2/2 mice (D). The percentage of cells with a-PCNA staining wasincreased in both the GsnWT (E) and the Gsn2/2 (F) glands at 12.5 dpc. Original magnification in A and B, 103, in C–F, 203
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
w416 Crowley et al.FIG. 5. Analysis of mammary gland remodeling following lactation and weaning in Gsn2/2 mice. Mammary gland involution occurred
normally after forced weaning of pups from both GsnWT (A) and Gsn2/2 (B) mice as assessed by TUNEL analysis of mammary glands 72 h
following weaning. TUNEL staining of mammary glands from involuting Gsn2/2 mice (B) revealed that removal of epithelial cells was
occurring via apoptosis (arrows in both A and B). Apoptosis was not evident in mammary glands taken from GsnWT or Gsn2/2 mice 24 h
after weaning (data not shown). Specificity of the TUNEL reaction was followed by staining adjacent sections with a-BrdU antibodyithout the addition of terminal deoxynucleotidyl transferase (data not shown). Original magnification in A and B, 403.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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417Gelsolin in Mouse Mammary Gland Morphogenesissource of the early block. SCID mice were used because
the early block was outcrossed from the late block and
kept on a mixed genetic background. Transplantations
(n 5 6) were performed essentially as described above
ith 3-week-old mice. Gsn2/2EB epithelium was trans-
planted into one cleared fourth inguinal fat pad, while
GsnWT epithelium was transplanted into the opposite
cleared fat pad. Only one mammary gland was removed
from each donor mouse, and they were maintained there-
after. The contralateral inguinal mammary gland of the
donor was removed at 10 –11 weeks, the termination of
the experiment, to determine the phenotype of the mam-
mary epithelium. The early block was present in three of
the donor mice as the mammary ductal epithelium had
just reached the lymph node by the termination of the
experiment (Fig. 8, Gsn2/2EB donor). Exposure of Gsn2/
2EB epithelium to the wild-type fat pad had caused the
release of the early block (Fig. 8, SCID FP/Gsn2/2 Epi).
In addition, terminal branching was normal in the Gsn2/
2EB transplanted epithelium (Fig. 8, SCID FP/Gsn2/2
pi). The other three donor mice did not retain the early
lock and the mammary gland in the SCID host appeared
ormal (data not shown). In all transplantations into the
snWT host, terminal branching of Gsn2/2EB and
sn2/2LB was equivalent to the GsnWT. These data
confirm the reciprocal transplantations above and sug-
gest that one or more modifier genes are acting in concert
with gelsolin through the stroma to orchestrate mam-
mary gland development.
FIG. 6. Proliferation of mammary epithelial cells in the Gsn2/2
snWT (A, C, and E) and Gsn2/2EB (B, D, and F) mice were injec
mmunohistochemistry using an a-BrdU antibody. Cellular prolife
in the process of mitosis; arrow in A. The Gsn2/2EB mice (B), on t
of the ducts. Proliferation was also observed in the ducts of GsnWT
id not demonstrate nuclear staining with the a-BrdU antibody in
ad a large percentage of cells in S phase (E). Proliferation was also d
ABLE 2
nalysis of Mammary Glands Undergoing Involution
t 72 h Postweaning
Total No.
of cellsa
TUNEL-positive
cells
Percentage
TUNEL
positiveb
Gsn2/2 72 h inv. 6757 329 4.86 6 0.16
GsnWT 72 h inv. 7890 391 4.96 6 0.33
a Represents the total number of cells counted in several random
elds per section from three individual fourth inguinal mammary
lands per genotype.
b The P value was derived by the Student t test for differences
etween means of percentage positives and was ,0.80.riginal magnification in A–D, 503, E and F, 203.
Copyright © 2000 by Academic Press. All rightDISCUSSION
Despite their outward appearance of having a normally
functioning mammary gland, mice which lack gelsolin do
not have normal ductal development as revealed by the
present study. Mammary glands from gelsolin-null
nonparous mice of the BALB/c 3 129/Sv background pos-
sessed two distinct phenotypes, delayed ductal outgrowth
in response to puberty and a lack of terminal end branching,
both of which are dependent on the genotype of the mam-
mary fat pad. Ductal morphogenesis normally begins in the
fourth postnatal week at the onset of puberty. Mammary
epithelial growth in the gelsolin-null mice, on the other
hand, did not start until approximately week 9, after which
time normal elongation of the ducts occurred. The mam-
mary anlage in the gelsolin-null mice has neither increased
proliferation nor increased apoptosis as determined by BrdU
incorporation and TUNEL analysis, respectively. Indeed,
TEBs are not present in the mammary glands of early block
Gsn2/2 mice until approximately week 10. Genetic influ-
ences in association with the loss of gelsolin are most likely
responsible for the failure of the mammary anlage to
undergo normal timing of elongation.
The block in mammary ductal growth in the Gsn2/2
ice was not due to defective hormonal stimulation as
xamination of vaginal smears from Gsn2/2 and GsnWT
ammary gland as assessed by bromodeoxyuridine incorporation.
ith BrdU (for details see Methods and Materials) and analyzed by
n was most intense in the TEBs of GsnWT (A) mice. One cell was
ther hand, showed a reduced amount of BrdU staining at the ends
mary glands (arrows in C). In contrast, Gsn2/2EB mammary glands
al cells (D). In mice at 9 weeks of age, the GsnWT epithelial cells
ted in the ductal epithelium of Gsn2/2EB age-matched females (F).
ABLE 3
ate of Cell Proliferation in Mammary Epithelium
f 7-Week-Old Gsn2/2EB and GsnWT Virgin Mice
Total No.
of cellsa
BrdU-positive
cells
Percentage
BrdU
positiveb
Gsn2/2EB 4433 159 3.57 6 0.36
GsnWT 5773 333 5.86 6 0.12
a All the epithelial cells from three independent sections repre-
enting three Gsn2/2EB mammary glands were counted while
approximately 30–50% of the epithelial cells from three indepen-
dent sections were counted, representing three GsnWT mammary
glands.
b The percentages are 6 standard error of the mean for N 5 3 and
P , 0.004. The P value was calculated using the Student t test for
differences between means of percentages positive.EB m
ted w
ratio
he o
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418 Crowley et al.mice indicated estrus cycling was essentially identical (our
unpublished observations). Moreover, female Gsn2/2 mice
ere competent for having a first pregnancy at the same age
s the GsnWT females (our unpublished observations).
FIG. 7. TUNEL assay to determine if the early block was due t
GsnWT (A) or Gsn2/2EB (B) females were assayed for the presence
ells in A and B (arrows) indicated that apoptosis had occurred in bo
(C and D) was processed identically except terminal deoxytransf
sections were counterstained in hematoxylin. Original magnificat
TABLE 4
TUNEL Analysis of Apoptotic Cells in Mammary Epithelium
of 7-Week-Old Virgin Mice
Total No.
of cellsa
TUNEL-positive
cells
Percentage TUNEL
positiveb
Gsn2/2EB 2950 14 0.475 6 0.34
GsnWT 9955 91 0.914 6 0.02
a See note to Table 3.
tb Statistics were done as in Table 2. P , 0.24.
Copyright © 2000 by Academic Press. All rightistological analysis failed to detect abnormalities in duc-
al architecture of mammary glands taken from any time
oint (data not shown). The delay in ductal epithelial
utgrowth was the original phenotype in the mammary
land of the gelsolin-null mouse. However, through random
reeding of our Gsn2/2 stocks we were able to separate the
arly block (delayed epithelial outgrowth) from the late
lock (lack of terminal branching). Similar breeding
chemes for the GsnWT mice never resulted in either
henotype (our unpublished observations). The initial
sn2/2 mice were produced from 129/Sv J1 embryonic
tem cells and then bred to BALB/c or C57Bl/6 mice (Witke
t al., 1995). Backcrosses of the Gsn2/2 mice to BALB/c or
57Bl/6 to establish the knockout on the BALB/c or
57Bl/6 backgrounds resulted in lethality between E17 and
ostnatal day 21 (Kwiatkowski, 1999). These results imply
increase in apoptosis. Mammary gland sections from 7-week-old
A fragmentation indicating apoptosis by TUNEL analysis. Brown
e normal and the Gsn2/2EB epithelium. The next adjacent section
was left out to control for nonspecific antibody reactions. The
as 503.o an
of DN
th th
erasehat in the presence of a modifier gene(s), gelsolin is
s of reproduction in any form reserved.
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419Gelsolin in Mouse Mammary Gland MorphogenesisFIG. 8. Transplantation analysis to determine the cell type origin of the incomplete ductal morphogenesis. Whole-mount analysis of
mammary fat pads transplanted with epithelium from GsnWT or Gsn2/2 females. GsnWT cleared mammary fat pads served as recipients
for either GsnWT epithelium (GsnWT FP/GsnWT Epi) or Gsn2/2 epithelium (GsnWT FP/Gsn2/2 Epi) and were analyzed 8 weeks
osttransplantation for the level and extent of branching morphogenesis of the epithelium. The mammary epithelium from the Gsn2/2
ice acquired the ability to form terminal ductal units and to develop alveoli (GsnWT FP/Gsn2/2 Epi). In contrast, epithelium from either
snWT mice or Gsn2/2 mice (Gsn2/2 FP/GsnWT Epi) failed to branch and did not undergo alveologenesis in cleared fat pads of Gsn2/2
ice. To determine the extent of signaling from the fat pad to the epithelium in the Gsn2/2EB mice, transplantations were done into SCIDecipients because of the Gsn2/2EB mixed genetic heritage. SCID fat pads are wild type for gelsolin. In all transplants (n 5 6) the Gsn2/2EB
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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420 Crowley et al.necessary for survival. Therefore, we hypothesize that a
modifier gene(s) in combination with the lack of gelsolin
contributed to the delay of ductal growth in Gsn2/2EB
mice. In addition, the genetic modifier may be derived from
the 129/Sv genome. Mating of a Gsn2/2 male to a 129/Sv
Gsn1/1 female with subsequent generation of Gsn2/2
mice resulted in recapitulation of the original early block
phenotype. However, the loss of the early block, and possi-
bly the 129/Sv component, in these animals may be a result
of genetic recombination and selection for the late block
phenotype in the later generations. The early block has
been maintained in the mixed genetic background by phe-
notyping mammary glands and mating Gsn2/2EB females
ith sibling males. These matings are approaching the F10
eneration. Despite this (or as a result of this) the early
lock is observed in approximately 50% of the females
enerated (our unpublished observations). To establish a
ure Gsn2/2EB line, backcrossing Gsn2/2EB females to
generate congenics at the modifier locus (or loci) would be
necessary. Regardless of the origin, the modifier(s) and lack
of gelsolin were signaling through the stroma to affect
ductal outgrowth, as transplantation of Gsn2/2EB epithe-
lium from early block mice into the cleared fat pad of SCID
mice (GsnWT stroma) demonstrated rescue from the early
block (Fig. 8, SCID FP/Gsn2/2 Epi). Experiments to assess
the genetic contribution to the mammary gland phenotype
in the gelsolin-null mice are ongoing in our laboratory.
Direct epithelial–stromal interactions are an absolute
requirement for normal embryonic and postnatal develop-
ment of the mammary gland (Cunha et al., 1996; Daniel and
Silberstein, 1987; Robinson et al., 1999; Sakakura, 1991).
The generation of gene deletions in the mouse has facili-
tated our understanding of some of the epithelial–stromal
signaling events involved in the growth, differentiation, and
function of the mammary gland. In several lines of knock-
out mice [e.g., epidermal growth factor receptor knockout
(EGFR-KO; Weisen et al., 1999), estrogen receptor knockout
(ERKO; Cunha et al., 1997), activin/inhibin bB (Robinson
nd Hennighausen, 1997), amphiregulin (Luetteke et al.,
999), and gelsolin (this study)] embryonic development of
he mammary gland occurred normally; however, ductal
longation beyond the mammary rudiment was impaired.
ransplantation analysis of mammary glands with these
arious deficiencies demonstrated that lack of expression in
he mammary stroma caused the observed phenotype (the
xception being amphiregulin for which tissue recombi-
ants were not done; Luetteke et al., 1999). In several other
nockout lines [e.g., prolactin (Horseman et al., 1997),
epithelium colonized the fat pad and gained the ability for terminal
transplanted from a GsnWT animal into the SCID fat pad showed
SCID fat pad was fully competent to direct mammary ductal morp
confirmed by whole-mount analysis of the contralateral mammary
while the other three did not at the termination of the experiment
Epi, Gsn2/2 FP/GsnWT Epi, and Gsn2/2 FP/Gsn2/2 Epi, 3.03; SCID
Copyright © 2000 by Academic Press. All rightrolactin receptor (Brisken et al., 1999), CCAAT/enhancer
binding protein-beta (Seagroves et al., 1998), and gelsolin
(this study)] terminal branching was absent in the adult
virgin mammary gland. Conversely, overexpression of cer-
tain growth regulatory genes [transforming growth factor-
beta (TGF-b; Pierce et al., 1993), truncated INT-3 (Smith et
al., 1995), stromelysin-1 (Witty et al., 1995), hepatocyte
growth factor (Yang et al., 1995), a dominant negative
TGF-b type II receptor (Gorska et al., 1998; Joseph et al.,
999), and PTHrP or PTH (Wysolmerski et al., 1995)] also
isrupts normal mammary gland development in the virgin
ouse. Several other genes have been shown to contribute
o aberrant mammary gland function in pregnancy, lacta-
ion, milk ejection reflex, and involution (reviewed in
ennighausen and Robinson, 1998). Many of these genes
re responsible for stromal–epithelial signaling as shown
hrough reciprocal transplantation experiments.
The results of our reciprocal transplantation experiments
Fig. 8) suggest gelsolin’s effects on mammary gland devel-
pment are mediated through the mammary stroma. Mam-
ary stroma–epithelial communication occurs through di-
erse signaling molecules (Brisken et al., 1999; Horseman,
997; Joseph et al., 1999; Ormandy et al., 1997; Pierce et al.,
993; Robinson et al., 1997; Robinson and Hennighausen,
997; Weisen et al., 1999; Wysolmerski et al., 1997, 1998).
or example, elegant studies by Daniel and co-workers
reviewed in Daniel et al., 1996; Robinson et al., 1991) using
low release pellets containing active forms of TGFb im-
planted in the mammary stroma ahead of the ductal tree
inhibited ductal elongation (Robinson et al., 1991). When
active TGFb was expressed in mammary epithelial cells
nder the direction of the mouse mammary tumor virus
romoter, primary and secondary ductal outgrowth of the
pithelial tree was essentially normal (Pierce et al., 1993).
owever, severe defects occurred in terminal branching,
nd TEBs persisted to 13 weeks of age (Pierce et al., 1993).
hese results were strikingly similar to those in the
elsolin-null mammary glands, wherein terminal branching
as reduced and TEBs persisted until 12 weeks of age.
dditionally, TGFb overexpressors were delayed in ductal
elongation, similar to Gsn2/2EB mammary glands, albeit
ot quite as severe, with the epithelium reaching the lymph
ode by 7 weeks of age (Pierce et al., 1993). The epithelium
n the Gsn2/2EB mice took 10–11 weeks to reach the
ymph node (Fig. 8, Gsn2/2EB donor). Gene ablation of
another TGFb family member, inhibin bB (bB), produced a
henotype similar to the Gsn2/2 mammary glands. Mice
ith a targeted deletion of the inhibin bB gene (Robinson
l branching and alveologenesis (SCID FP/Gsn2/2 Epi). Epithelium
entical pattern of ductal morphogenesis, which suggested that the
nesis (SCID FP/GsnWT Epi). The presence of the early block was
d. Three of the donor animals (Donor) contained the early block,
ginal magnification, GsnWT FP/Gsn2/2 Epi, GsnWT FP/GsnWTducta
an id
hoge
glan
. Ori
FP/GsnWT or Gsn2/2 Epi, 2.03; Donor, 1.53.
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421Gelsolin in Mouse Mammary Gland Morphogenesisand Hennighausen, 1997) had a delay in ductal outgrowth
during puberty similar to the Gsn2/2EB mice. Lobuloalveo-
lar development during pregnancy in the bB null mice was
severely delayed, as very little functional differentiation
had occurred even at day 18 of pregnancy (Robinson and
Hennighausen, 1997). This slow lobuloalveolar develop-
ment during pregnancy was also observed in the Gsn2/2
mammary glands, although the Gsn2/2 mice were able to
lactate normally in contrast to the inhibin bB-deficient
mice. The effects of gelsolin deficiency mimicked those of
inhibin bB (Robinson and Hennighausen, 1997) in that
transplantation analysis indicated that the defect was de-
pendent on signaling from the stroma. In further support of
TGFb’s involvement in stroma to epithelial signaling, ex-
ression of a dominant negative TGFb type II receptor
nder the control of a metallothionein gene promoter
expression restricted to fibroblasts in the mammary
troma) resulted in increased lateral branching in the virgin
ammary gland (Joseph et al., 1999). Together these results
uggest that normal TGFb signaling orchestrates ductal
ranching in the developing mammary gland. The recipro-
al experiment, expression of the dominant negative TGF-b
type II receptor in mammary epithelium, stimulated preco-
cious alveolar development in the virgin mouse (Gorska et
l., 1998), suggesting that the cellular responses to TGFb
are cell type specific.
Stimulation of the EGF and TGFb receptors has been
hown by several investigators to cause reorganization of
he actin cytoskeleton, and reorganization is necessary for
ell motility in response to EGF (Chen et al, 1996;
oomber, 1991; Moustakas and Stournaras, 1999; Xie et al.,
998). Therefore, actin cytoskeleton reorganization per se
ay be responsible for the lack of ductal outgrowth seen in
he gelsolin-null mammary glands. Altered actin dynamics
an induce transcriptional regulation through serum re-
ponse factor (SRF) as shown for the actin-binding/severing
rotein, cofilin (Sotiropoulos et al., 1999). Gelsolin reorga-
izes the actin cytoskeleton through actin severing and
inds two actin monomers, thereby providing nucleation
ites and altering the levels of F- and G-actin. The lack of
elsolin within stromal cells of the mammary fat pad may
herefore have at least one of two possible effects: an
ncrease in the overall amount of free G-actin due to the
bsence of the two monomer binding sites on gelsolin or
ncreased filament stability and a decreased amount of free
-actin due to the loss of actin filament severing activity.
ither of these two possibilities could result in altered SRF
or other transcription factors dependent on actin dynamics)
ctivation and lead to altered kinetics of transcriptional
egulation. Alternatively, the loss of gelsolin’s association
ith several signaling components (e.g., phospholipase D,
IP2, PI3 kinase, and the EGFR) in the null mice may alter
ignal transduction pathways which are required for proper
pithelial–stromal communication and normal mammary
land morphogenesis. It is surprising that the gelsolin
efect is stromal and not epithelial in nature, since it would
ppear that the mammary epithelial cells are by far the
Copyright © 2000 by Academic Press. All rightost motile during puberty. However, these results are
imilar to those seen in the EGFR-KOs and ERKOs and
uggest that gelsolin facilitates a critical epithelial–stromal
nteraction during mammary gland development. It is also
ossible that the lack of secreted gelsolin, known to be
resent in the mammary interstitium, could be important.
owever, motility signaling defects in stromal cells seem
ore likely. Experiments to identify the underlying mo-
ecular mechanisms are currently in progress.
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